Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
102M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
612K
-
Shares change
-
+312K
-
Total reported value, excl. options
-
$441K
-
Value change
-
+$225K
-
Number of buys
-
12
-
Number of sells
-
-5
-
Price
-
$0.73
Significant Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA) as of Q3 2025
20 filings reported holding KTTA - Pasithea Therapeutics Corp. - Common Stock as of Q3 2025.
Pasithea Therapeutics Corp. - Common Stock (KTTA) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 612K shares
of 102M outstanding shares and own 0.6% of the company stock.
Largest 10 shareholders include AdvisorShares Investments LLC (258K shares), CITADEL ADVISORS LLC (67.3K shares), VANGUARD GROUP INC (53.8K shares), TWO SIGMA INVESTMENTS, LP (35.8K shares), XTX Topco Ltd (34.4K shares), RENAISSANCE TECHNOLOGIES LLC (30.7K shares), GEODE CAPITAL MANAGEMENT, LLC (25.5K shares), Virtu Financial LLC (25.1K shares), JANE STREET GROUP, LLC (25.1K shares), and TWO SIGMA SECURITIES, LLC (20.8K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.